Menu Search
Equities

MD Medical Group Investments PLC

MDMG:MCX

MD Medical Group Investments PLC

Actions
  • Price (RUB)1,056.70
  • Today's Change-43.30 / -3.94%
  • Shares traded187.32k
  • 1 Year change+90.50%
  • Beta--
Data delayed at least 30 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MD Medical Group Investments Plc is an investment holding company. The Company is a provider of private healthcare for women and children. The Company's services include obstetrics and gynecology, pediatrics, fertility and in vitro fertilization (IVF) treatment, and other services, including laboratory services, stem cell storage, trauma, rehabilitation, dental care and surgery, among other services. The Company operates 23 medical centers across Russia, which includes four hospitals and 19 out-patient clinics in Moscow, Ryazan, Yaroslavl, St. Petersburg, Samara and Samara Region, Perm, Ufa, Novosibirsk and Irkutsk. It offers both in-patient care hospitals and out-patient care clinics. The Company owns its own laboratory, stem cell bank and ambulance service.

  • Revenue in RUB (TTM)25.92bn
  • Net income in RUB6.81bn
  • Incorporated2010
  • Employees8.47k
  • Location
    MD Medical Group Investments PLC2nd floor, office #784, Spyrou Kyprianou AvenueNICOSIA 2024CyprusCYP
  • Phone+357 22504000
  • Fax+357 22504100
  • Websitehttps://www.mcclinics.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		MDMG:MCX since
announced		Transaction
value
University Medical and Surgical CenterDeal completed17 Jul 202317 Jul 2023Deal completed63.27%--
Data delayed at least 30 minutes, as of May 16 2024.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.